These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 15453345)

  • 1. [Development of cirrhosis after chronic hepatitis B].
    Hazama H; Koga M
    Nihon Rinsho; 2004 Aug; 62 Suppl 8():354-7. PubMed ID: 15453345
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical aspects of liver cirrhosis, type B].
    Yamada G
    Nihon Rinsho; 2004 Aug; 62 Suppl 8():349-53. PubMed ID: 15453344
    [No Abstract]   [Full Text] [Related]  

  • 3. Hepatitis B viral factors and clinical outcomes of chronic hepatitis B.
    Lin CL; Kao JH
    J Biomed Sci; 2008 Mar; 15(2):137-45. PubMed ID: 18058038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in liver histology as a "surrogate" end point of antiviral therapy for chronic HBV can predict progression to liver complications.
    Hui CK; Leung N; Shek WH; Zhang HY; Luk JM; Poon RT; Lo CM; Fan ST; Lau GK;
    J Clin Gastroenterol; 2008; 42(5):533-8. PubMed ID: 18344885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pre-S deletion and complex mutations of hepatitis B virus related to advanced liver disease in HBeAg-negative patients.
    Chen CH; Hung CH; Lee CM; Hu TH; Wang JH; Wang JC; Lu SN; Changchien CS
    Gastroenterology; 2007 Nov; 133(5):1466-74. PubMed ID: 17915220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Natural course and prognosis in asymptomatic carriers of hepatitis B virus].
    Suzuki K; Abe K; Kumagai I
    Nihon Rinsho; 2004 Aug; 62 Suppl 8():227-32. PubMed ID: 15453320
    [No Abstract]   [Full Text] [Related]  

  • 7. Incidence and risk factors of progression to cirrhosis in inactive carriers of hepatitis B virus.
    Chu CM; Liaw YF
    Am J Gastroenterol; 2009 Jul; 104(7):1693-9. PubMed ID: 19455130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [HBe antigen and HBe antibody].
    Arase Y
    Nihon Rinsho; 2004 Aug; 62 Suppl 8():124-8. PubMed ID: 15453300
    [No Abstract]   [Full Text] [Related]  

  • 9. Precore stop mutant in anti-HBe-positive phases of chronic hepatitis B virus infection.
    Chu CM
    Am J Gastroenterol; 2002 Aug; 97(8):2138-9; author reply 2139-40. PubMed ID: 12190193
    [No Abstract]   [Full Text] [Related]  

  • 10. Natural history of chronic hepatitis B REVEALed.
    Chen CJ; Yang HI
    J Gastroenterol Hepatol; 2011 Apr; 26(4):628-38. PubMed ID: 21323729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors associated with the intensity of liver fibrosis in renal transplant patients with hepatitis B virus infection.
    Matos CA; Perez RM; Lemos LB; Medina-Pestana JO; Lanzoni VP; Alberto FL; Moreira ES; Silva AE; Ferraz ML
    Eur J Gastroenterol Hepatol; 2007 Aug; 19(8):653-7. PubMed ID: 17625434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Massive splenomegaly with pancytopenia in children and adolescents with hepatitis B cirrhosis.
    Mirza R; Z A; Z A; Nh L
    J Coll Physicians Surg Pak; 2006 Sep; 16(9):629-30. PubMed ID: 16945246
    [No Abstract]   [Full Text] [Related]  

  • 13. Carriers of inactive hepatitis B virus are still at risk for hepatocellular carcinoma and liver-related death.
    Chen JD; Yang HI; Iloeje UH; You SL; Lu SN; Wang LY; Su J; Sun CA; Liaw YF; Chen CJ;
    Gastroenterology; 2010 May; 138(5):1747-54. PubMed ID: 20114048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term follow-up of interferon alfa treatment in Chinese patients with chronic hepatitis B infection: The effect on hepatitis B e antigen seroconversion and the development of cirrhosis-related complications.
    Yuen MF; Hui CK; Cheng CC; Wu CH; Lai YP; Lai CL
    Hepatology; 2001 Jul; 34(1):139-45. PubMed ID: 11431745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting cirrhosis risk based on the level of circulating hepatitis B viral load.
    Iloeje UH; Yang HI; Su J; Jen CL; You SL; Chen CJ;
    Gastroenterology; 2006 Mar; 130(3):678-86. PubMed ID: 16530509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease.
    Cacciola I; Pollicino T; Squadrito G; Cerenzia G; Orlando ME; Raimondo G
    N Engl J Med; 1999 Jul; 341(1):22-6. PubMed ID: 10387938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical improvement in patients with decompensated liver disease caused by hepatitis B after treatment with lamivudine.
    Sponseller CA; Bacon BR; Di Bisceglie AM
    Liver Transpl; 2000 Nov; 6(6):715-20. PubMed ID: 11084057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of serial measurement of serum HBV DNA levels in patients with chronic HBeAg(-) hepatitis B infection: association with liver disease progression. A prospective cohort study.
    Zacharakis G; Koskinas J; Kotsiou S; Tzara F; Vafeiadis N; Papoutselis M; Maltezos E; Sivridis E; Papoutselis K
    J Hepatol; 2008 Dec; 49(6):884-91. PubMed ID: 18674840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mechanisms of hepatitis B e antigen seroconversion from the aspect of viral mutation].
    Torii N; Hasegawa K; Oomori K; Shiratori K
    Nihon Rinsho; 2004 Aug; 62 Suppl 8():93-7. PubMed ID: 15453294
    [No Abstract]   [Full Text] [Related]  

  • 20. Impact of occult hepatitis B virus infection and prior hepatitis B virus infection on development of hepatocellular carcinoma in patients with liver cirrhosis due to hepatitis C virus.
    Adachi S; Shibuya A; Miura Y; Takeuchi A; Nakazawa T; Saigenji K
    Scand J Gastroenterol; 2008; 43(7):849-56. PubMed ID: 18584524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.